{"name":"Vor Biopharma","slug":"vor-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":321532000,"netIncome":-695981000,"cash":396486000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOZ212djJQOGFIUzN6cXpvY244amNlQllmRmhya2ZYZG01dy1SVUVZOFFMZlVYWTZTN0JTZldYNkw1ejZVTVV4aWdVVVQybWhSNk9UTWtGQ2hPbU5JdGdLSTRHa2RLclRMNWcwMHFyLUdOM3hUbFYyTFhjODhDeFBOTS1VczNVSDlP?oc=5","date":"2026-04-08","type":"pipeline","source":"Seeking Alpha","summary":"Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR) - Seeking Alpha","headline":"Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR)","sentiment":"neutral"},{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNUZLQkM1bGVIekpucEl4Z04wSVowNXh5MzUwdHdSR3NYanpHV3ZyQ0hqZnd4LUFRaG9RTXNOLXdfdGJhX1FnMnlsY0RrSXVDdTduelJEa2tIVXZ6VHRuMXh2dzJZQ3BwN2p1aWRvb2V2S3l0TXRQakdXZDdtRHZnUGl5ZFZ2YlhTb3BHRHNhcHFlclBmVXIzRHcyeDRuZw?oc=5","date":"2025-11-07","type":"pipeline","source":"Fierce Biotech","summary":"Recursion refreshes leadership with CEO swap—Chutes & Ladders - Fierce Biotech","headline":"Recursion refreshes leadership with CEO swap—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOcUZYRE00dXpJVGljUW11TkN4TU1zMGZOUE8xdmNVd0hQcGRDUVh0VVF3N3NaWnkwaUJOekdqZjNxQm1qVzduSS0zTllBTmRGNXdTYVo3clQydVkydUdsX0ttRUhKLVljVmlzS0VYU0doVWhsR0ZBQVNXazRGQWlDZVFDd2lZdUR6MkpuRGd6ZWs5U3I3LXEyc1dqOHFTaExfemc?oc=5","date":"2025-09-25","type":"deal","source":"Seeking Alpha","summary":"Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha","headline":"Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPV25pYzVzX0thUm5nVm1fU1M4Sk1mNnhKblVhano1dl9aRkg2SnpoZEJERy1yZ2swVEw3NE5Bb2F2bDh2ME5MX3RrVGpFYmc3WXhpVW9BWmNyTVg4TDJEMWx5bGZydUJ6MlhFQlZUMjI2RVJYa0REc1EtbUE2QkJKeFBlR3REVU1HZ1RWYkx4Nm1wbHgy?oc=5","date":"2025-08-13","type":"trial","source":"BioPharma Dive","summary":"Vor says drug licensed from RemeGen succeeded in Sjögren’s study - BioPharma Dive","headline":"Vor says drug licensed from RemeGen succeeded in Sjögren’s study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVg2eEJGTzJEVUJ2Y1lhRnc5SXdWM1htajFPVE5LTGxUNk8tQWh2N3RFaGE4X01XY3A3OUdIcVd6aDdxdnJ1MEUtMFh6UGJqaUp6bHNwb29mVDU3X0hoS3VTdHdkazdLajN4WnRhSXFLSW9MNjhWZmRRZUJ3dlRYelJvSkhjX3hOcW1mZGpZa1N2SXJWX2FseTVySzZtdWNMSkcxV3Zybw?oc=5","date":"2025-06-27","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod - Fierce Pharma","headline":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNclpRSGx0Z014ai1mU1VJYWptV1FNUlNLYWdiLWdRMWpOTUJMV21TX3c3WDV5NDF5bUtHTXV1dDcxTGkyY1RMaElDWHNDVFA0cl9nYlJsUGxtOUJ2STYySVotU05iZVFPRThscC10WFB1blQtTlZsaFU3bjB0UnJ3cWNPZGxvalFvcExhb1djRklzM2k4QklqUDdSLTlNenhxQnM2bG14WnUzQzlwX2tMbWFhSDFncXIyM1l3Y0VfQW54R0FYekE?oc=5","date":"2025-06-26","type":"deal","source":"Fierce Pharma","summary":"Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions - Fierce Pharma","headline":"Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNY2tfTzVoTzV3MmlWLTJRODFfSThONVhLQjBFQzdEM3pfc3h3bzc1MGhnRm13LTJYQ0FfOTFrVGgwT01CdGZHd1Z5dTJ0eDlJV2o0RmRKX0pQNVZKbnh2YnhFbjctRXRiUWFaam9hYXk0R0tNaWt5UlFMVk5PN3d1UkJyZw?oc=5","date":"2025-06-26","type":"pipeline","source":"BioPharma Dive","summary":"Vor, with new CEO, changes course to target autoimmune disease - BioPharma Dive","headline":"Vor, with new CEO, changes course to target autoimmune disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPa1c2VkNnS0NCOVBEYkdYMHlOdUFueDVuWkdJUldkX2haNWxwamZOMEMwbU1nR0xEeUhtS040VE14UzRqQVNBbE81X1FNc21aN2pjWi1aSlFaelE5ZFpYNGJaMDREOGZHVVVLbGpWb0ZhQXdJLWtQdUc1RURLdjRjWFBRNGdJNU1pLWE4QWpnQ1pqa01QQ3VYUjhPQkExMzczaW53alZ4MEdqZTJjLWdVMEh4c3JGQQ?oc=5","date":"2025-06-26","type":"trial","source":"MedCity News","summary":"Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in Funding - MedCity News","headline":"Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQV3lOU1FDekVqQ0J4MkNORDEta0hFT1NwT2xUb1daMGxReFE2a1otc0ZIX1ZfbmEyMXVMckdNSklzUGhVUWF6d3VLUXNnZmdMNjRSdXZ1T2kyR2xjejJQYjRsU0M4RXVvSU42RGtJYmNPQlJId0M2U3E1b1pZZ1VDd092cHhUQQ?oc=5","date":"2025-06-26","type":"deal","source":"pharmaphorum","summary":"Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen - pharmaphorum","headline":"Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPLUpjTko2dFJaalg2T2Q1bXdNaHVVRHpKSGo2czRoSVJYZTJzWWs4aWZJcTV4TExFTldqbXQ0RDNmTTJxbTZCSmpnU1Y1S0ltX296OXdKb3RiaVRjMVczVTFJQjZZTUIwMjF6b1d6ZVJvR1NhSm9wTWJRUVRZOFBPWDBWRQ?oc=5","date":"2025-05-09","type":"pipeline","source":"pharmaphorum","summary":"Vor Bio winding down as multiple biotechs downsize - pharmaphorum","headline":"Vor Bio winding down as multiple biotechs downsize","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5iQmNJZk9HS09QTUxQaXowVDM3MkpCbU9velBONWpNbnR3QmVZNklEdDh5NWphWHZuX0NYX1N0ZXQ2U2FzcDMxVklQMXNvcERlenlr?oc=5","date":"2025-05-08","type":"pipeline","source":"FirstWord Pharma","summary":"Layoffs hit biotech: Vor Bio slashes 95% of staff, more cuts from insitro, Korro, Rallybio - FirstWord Pharma","headline":"Layoffs hit biotech: Vor Bio slashes 95% of staff, more cuts from insitro, Korro, Rallybio","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":321532000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-695981000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":396486000,"cashHistory":[],"totalAssets":464126000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}